Gene Transfer Approaches for Gynecological Diseases

This publication has 84 references indexed in Scilit:

• Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy
  The Journal of Gene Medicine, 2004
• Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor
  Cancer Gene Therapy, 2004
• Gene transfer to cervical cancer with fiber‐modified adenoviruses
  International Journal of Cancer, 2004
• Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids
  Cancer Gene Therapy, 2003
• Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
  Cancer Gene Therapy, 2002
• Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer
  Journal of Clinical Oncology, 2002
• Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up
  Gynecologic Oncology, 2001
• Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes
  Gene Therapy, 2001
• Targeted Eradication of Ovarian Cancer Mediated by Intracellular Expression of Anti-erbB-2 Single-Chain Antibody
  Gynecologic Oncology, 1995
• Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  JNCI Journal of the National Cancer Institute, 1995